ES398016A1 - Procedimiento para el aislamiento de factor estabilizador- de fibrina. - Google Patents

Procedimiento para el aislamiento de factor estabilizador- de fibrina.

Info

Publication number
ES398016A1
ES398016A1 ES398016A ES398016A ES398016A1 ES 398016 A1 ES398016 A1 ES 398016A1 ES 398016 A ES398016 A ES 398016A ES 398016 A ES398016 A ES 398016A ES 398016 A1 ES398016 A1 ES 398016A1
Authority
ES
Spain
Prior art keywords
solution
nacl
alkali metal
neutral
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES398016A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES398016A1 publication Critical patent/ES398016A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES398016A 1970-12-22 1971-12-16 Procedimiento para el aislamiento de factor estabilizador- de fibrina. Expired ES398016A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2063070A DE2063070C3 (de) 1970-12-22 1970-12-22 Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung

Publications (1)

Publication Number Publication Date
ES398016A1 true ES398016A1 (es) 1974-07-16

Family

ID=5791794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES398016A Expired ES398016A1 (es) 1970-12-22 1971-12-16 Procedimiento para el aislamiento de factor estabilizador- de fibrina.

Country Status (15)

Country Link
JP (1) JPS5421402B1 (en:Method)
AT (1) AT310941B (en:Method)
AU (1) AU432182B2 (en:Method)
BE (1) BE777136A (en:Method)
BR (1) BR7108490D0 (en:Method)
CA (1) CA957943A (en:Method)
CH (1) CH575235A5 (en:Method)
DE (1) DE2063070C3 (en:Method)
DK (1) DK127227B (en:Method)
ES (1) ES398016A1 (en:Method)
FR (1) FR2119009B1 (en:Method)
GB (1) GB1380056A (en:Method)
IL (1) IL38403A (en:Method)
NL (1) NL159582B (en:Method)
SE (1) SE371930B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454745B (sv) * 1982-12-10 1988-05-30 Cubana Importadora Y Exportado Produkt for att stimulera syntesen av melanotiskt pigment i huden vid botande av vigiligo
FR2600078B1 (fr) * 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
WO1991000098A1 (fr) * 1989-06-23 1991-01-10 Kishinevsky Selskokhozyaistvenny Institut Imeni M.V.Frunze Preparation anti-inflammatoire et son procede d'obtention
DE19508192A1 (de) 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
DE2063070C3 (de) 1975-07-24
AU3708871A (en) 1973-02-15
SE371930B (en:Method) 1974-12-09
GB1380056A (en) 1975-01-08
IL38403A0 (en) 1972-02-29
FR2119009B1 (en:Method) 1975-03-14
BE777136A (fr) 1972-06-22
DE2063070A1 (de) 1972-06-29
CH575235A5 (en:Method) 1976-05-14
AU432182B2 (en) 1973-02-15
CA957943A (en) 1974-11-19
AT310941B (de) 1973-10-25
NL159582B (nl) 1979-03-15
JPS5421402B1 (en:Method) 1979-07-30
FR2119009A1 (en:Method) 1972-08-04
DE2063070B2 (de) 1974-12-05
IL38403A (en) 1975-04-25
NL7117363A (en:Method) 1972-06-26
BR7108490D0 (pt) 1973-05-08
DK127227B (da) 1973-10-08

Similar Documents

Publication Publication Date Title
KR840004365A (ko) 종양괴사 인자의 안정화방법
DE2440529C3 (de) Hyaluronidase-Präparat aus menschlicher Plazenta
ES398016A1 (es) Procedimiento para el aislamiento de factor estabilizador- de fibrina.
Bernheim et al. Oxidation of acetylcholine by tissues
Von Euler et al. Occurrence of a substance P-like polypeptide in fish intestine and brain
CO5021217A1 (es) Composiciones estables de mitoxantrona, procedimietno para prepararlas; utilizacion de dichas composiciones y medica- mentos que incluyen dichas soluciones para el tratamiento de enfermedades cancerosas
Paul et al. Cyclophorase System, XXII. Cyclophorase System of Rabbit Heart Muscle.
Leone Ergothioneine in the equine ampullar secretion
GB444276A (en) An improved process for the manufacture of medicinal preparations containing chlorophyll or chlorophylline
ES398015A1 (es) Procedimiento para el aislamiento de un factor estabiliza- dor de fibrina.
GB1030605A (en) Calcitonin, a blood-calcium reducer
ES395433A1 (es) Procedimiento para la estabilizacion de una solucion acuosainyectable.
KR860001827A (ko) 다당체 rin 물질, 그 제조법과 용도
GB452000A (en) Improvements in or relating to dialysis
GB929642A (en) Sweetening agent
HASHIMOTO et al. ACTIVATION OF GLYCERATE 2, 3-DIPHOSPHATASE BY MERCURIC ION
GB1056192A (en) Pharmaceutical compositions containing catalase
Davis et al. A Vasopressor Phenomenon Following Intra-arterial Administration of Hypertonic Solutions
GB634566A (en) Preparation for treating the human body and process for the manufacture of such preparations
Arglebe et al. Hyperamylasaemia in isoprenaline-induced experimental sialadenosis in the rat
SE9302006D0 (sv) Protein formulation
DE2023447A1 (de) Insulinderivate und Verfahren zu ihrer Herstellung
Nicol et al. Effect of Ethisterone, β-Œstradiol and Progesterone on the Phagocytic Activity of the Reticulo-Endothelial System
GB207573A (en) Process of making medicinal preparations
US2324848A (en) Process of preparing antianemic concentrates